Sukino Continuum Care, a pioneer in India's post-hospital rehabilitation space, has raised $31 million in a Series B funding round. The investment was led by global VC giant Bessemer Venture Partners, with significant participation from Rainmatter by Zerodha.

Founded in 2016 by Rajinish M. and Shalini Menon, Sukino operates in a critical but often overlooked segment: what happens to a patient after they are discharged from the ICU but aren't ready to go home? This "step-down" care model is standard in the West but is just finding its footing in India.

FounderStory Intelligence

Current Scale
850+ Beds
Financial Health
Profitable
64% YoY Growth
Founders (2016)
Rajinish M. | Shalini Menon
Official Data & Links

Bridging the Care Gap

Sukino specializes in post-acute rehabilitation for patients recovering from stroke, neurological disorders, orthopedic surgeries, and cancer. Their facilities act as a bridge between the high-intensity environment of a hospital and the home.

Currently managing 11 centers with over 850 beds, the company has achieved profitability at a group level while maintaining a rapid 64% year-on-year growth rate.

Aggressive Expansion Plans

The fresh capital will be deployed to triple their footprint. Sukino plans to open 22 new centers over the next two years, expanding geographically beyond their stronghold in Bengaluru.

The investment from Rainmatter (Zerodha) is particularly notable, as the fund typically backs businesses that focus on health, sustainability, and long-term value creation rather than quick flips.

"Investors are betting big on India's under-penetrated post-hospital care segment... Sukino operates 850+ beds across 11 centres and is profitable at a group level."

FounderStory Takeaway

As India's life expectancy increases and critical care improves, the need for "Continuum Care" is exploding. Hospitals are for surgeries; homes are for living. Sukino fills the crucial recovery void in between. Being profitable while scaling physical infrastructure is a rare feat in the Indian startup ecosystem, making this Series B a strong validation of their operational excellence.